CCN1 and breast carcinoma: Pendurthi et al. reported that plasmin, one of the protease families that has been involved in many cellular processes via the proteolytic cleavage to the extracellular matrix (ECM), has the potential ability to up-regulate the truncated form of CCN1 in breast carcinoma cells [39].